Bowel Cleansing
10
0
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
40%
4 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease
Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population
Unrestricted Diet for Screening Colonoscopy
Drug Use-Results Survey on Picoprep® Combination Powder
LINE Re-education Before Colonoscopy to Confirm Optimal Bowel Cleansing
Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy
Eziclen Drug Utilisation in Real Life Setting
Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule
A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy
Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies